Search

Searching with a thematic focus on HIV and AIDS, ARVs, HIV and AIDS treatment and care

Showing 91-100 of 162 results

Pages

• Document

  Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

  The Lancet, 2004

  Trials of a low-cost antibiotic drug with HIV infected children in Zambia have been stopped early when it became clear that the drug nearly halved the mortality rate compared with placebo. The researchers argue that the co-trimoxazole drug should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia. The tr
• Document

  Reducing maternal and neonatal mortality in the poorest communities

  British Medical Journal, 2004

  This article from the British Medical Journal (BMJ) asserts that current safe motherhood and newborn care programmes, which emphasise skilled attendance and institutional delivery, are failing to reach the poorest populations. This is because the poorest mothers are more likely to deliver at home than in a health facility.
• Document

  Treating AIDS now: an opportunity for the UK to lead the world in bringing AIDS treatment to all who need it

  People and Planet, 2004

  This paper is a call to action for the UK government to use its international leadership to increase access to HIV/AIDS treatment. The paper outlines the case for antiretrovirals (ARV), as well as the key role of drug costs in determining access to ARVs. It then makes the case for expanding generic drug production in developing countries and explores the barriers to this expansion.
• Document

  Technical guide for HIV/AIDS medicines and related supplies: contemporary context and procurement

  World Bank, 2004

  This guide from the World Bank sets out principles and advice for the procurement of HIV/AIDS medicines and related supplies for scaling up antiretroviral therapy (ART) and associated health services. It is aimed at World Bank staff, as well as those responsible for procuring HIV/AIDS medicines and related supplies in Bank-funded programmes and projects.
• Document

  Financing issues in proposed HIV/AIDS intervention of providing anti-retroviral drugs to selected regions in India

  Indian Institute of Management, Ahmedabad, 2004

  The development of antiretroviral therapy has given a new hope for people living with Acquired Immuno Deficiency Syndrome (AIDS). In the face of increased disease burden due to AIDS the global and political commitment towards controlling the pandemic has received renewed thrust in recent times.
• Document

  AIDS In India: public health related aspects of industrial and intellectual property rights policies in a developing country

  Centre de Sciences Humaines, New Delhi, 2004

  By 2004, an estimated 40 million people world-wide are infected by the Acquired Immuno-Deficiency Syndrome (AIDS) or the Human Immuno-Deficiency Virus (HIV). The epidemic essentially affects developing countries (DCs), and India is no exception, with reported cases numbering around 4 million.
• Document

  HIV/AIDS as a security issue in Africa: lessons from Uganda

  International Crisis Group, 2004

  This report is the third in a series on HIV/AIDS as a security issue from the International Crisis Group (ICG), and draws on the policy experience of Uganda. The report asserts that HIV/AIDS prevention and conflict prevention should go hand in hand: evidence suggests that war can lead to increased risks of HIV/AIDS and HIV/AIDS can make conflicts worse.
• Document

  Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township

  Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, 2004

  Many HIV-positive adults in South Africa are dependent on the resource-constrained public sector healthcare system. There is therefore a clear need for research on the costs and effectiveness of different treatments for HIV.
• Document

  The Zambia HIV/AIDS workforce study: preparing for scale-up

  US Agency for International Development, 2004

  Anticipating significant scale-up of its current HIV/AIDS services, the Zambian Central Board of Health commissioned this study of the human resource implications. The study collected data at 16 government, NGO, and private for-profit sites across Zambia that currently provide VCT, P-MTCT, and ART services.
• Document

  Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis

  The Lancet, 2004

  This article, published in The Lancet, considers strategies for providing antiretroviral treatment to three million people with HIV/AIDS by 2005 (the ‘3 by 5’ target), drawing on lessons from the Green Light Committee’s expansion of treatment for multidrug-resistant tuberculosis (MDR-TB).

Pages